Prestige Biologics Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Prestige Biologics Co Ltd

Watchlist Manager

Watchlist

Price: 1 721 KRW -1.83% Market Closed

Market Cap: ₩133.8B

P	Prestige Biologics Co Ltd KOSDAQ:334970	KR
	Cencora Inc NYSE:COR	US
	Auburn Bancorp Inc OTC:ABBB	US
K	Kyungdong Pharm KOSDAQ:011040	KR

Profitability Summary

Prestige Biologics Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Negative Gross Margin

-104%

Negative 3Y Average Gross Margin

-223%

Declining Gross Margin

30% > -104%

Negative Operating Margin

-243%

Negative 3Y Average Operating Margin

-899%

Operating Margin is Increasing

-1 278% > -243%

Negative Net Margin

-196%

Negative 3Y Average Net Margin

-734%

Net Margin is Increasing

-1 039% > -196%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-591%

Free Cash Flow Margin is Increasing

-1 384% > 1%

Negative ROE

-29%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-14%

Declining ROIC

-9% > -17%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.